| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 10/04/2007 | US20070232904 Application of Hyaluronic Acid to Sentinel Lymph Node Identification |
| 10/04/2007 | US20070232600 Anti-migraine treatments |
| 10/04/2007 | US20070231352 Mucoadhesive thermoresponsive medicament-carrier composition |
| 10/04/2007 | US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 10/04/2007 | US20070231266 Diagnosis of macrophage mediated disease |
| 10/04/2007 | US20070231265 Cell growth factor of hair stem cell factor induces migration of melanocyte stem cells and keratinocyte stem cells to increase in hair follicles, amino acids and vitamins, and minoxidil; animal models |
| 10/04/2007 | US20070231264 Mammalian cytokine; related reagents |
| 10/04/2007 | US20070231263 Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders |
| 10/04/2007 | US20070231262 Hepatitis C virus variants |
| 10/04/2007 | US20070231260 Transporter-targeted methods of diagnosis and treatment |
| 10/04/2007 | US20070231259 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 10/04/2007 | CA2645946A1 Inhibitors of protein aggregation |
| 10/03/2007 | EP1839677A1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof |
| 10/03/2007 | EP1839660A1 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
| 10/03/2007 | EP1838730A2 Pan-her antagonists and methods of use |
| 10/03/2007 | EP1412383B9 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) |
| 10/03/2007 | EP1287359B1 Silica coated nanoparticles |
| 10/03/2007 | EP1267839B1 Microspheres for active embolization |
| 10/03/2007 | EP1262490B1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 10/03/2007 | CN101048225A Preparation of dispersions of particles for use as contrast agents in ultrasound imaging |
| 10/03/2007 | CN101048224A Apparatus and methods for the production of ultrasound contrast agents |
| 10/03/2007 | CN101045167A Method for quantitative determination of in vivo activity of recombination human endothelial chalone |
| 10/03/2007 | CN100340298C Near infrared fluorescent contrast agent and method for fluorescence imaging |
| 10/03/2007 | CN100340291C F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 10/02/2007 | US7277775 Automated dynamic pressure-responsive dispensing systems, and associated methods and computer program products |
| 10/02/2007 | US7276494 Photodynamic therapy; anticancer agents, vision defects, autoimmune disease, restenosis, skin disorders; cancer vaccine; medical diagnosis |
| 10/02/2007 | US7276350 Method for diagnosing infectious diseases |
| 10/02/2007 | US7276228 Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase |
| 10/02/2007 | US7276227 Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 09/27/2007 | WO2007109364A2 Intramolecularly quenched fluorochrome conjugates and methods of use |
| 09/27/2007 | WO2007109121A2 A zebrafish model for assessing gastrointestinal motility |
| 09/27/2007 | WO2007027584A3 Deposit contrast agents and related methods thereof |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070225210 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 09/27/2007 | US20070224653 Methods for Modulating an Immune Response by Modulating Krc Activity |
| 09/27/2007 | US20070224128 Drug adherence monitoring system |
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | US20070224126 Index and Method of use of Adapted Food Compositions for Dysphagic Persons |
| 09/27/2007 | US20070224125 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 09/27/2007 | US20070224124 Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein |
| 09/27/2007 | US20070224123 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/27/2007 | US20070224122 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 09/27/2007 | CA2643102A1 A method for noninvasively and quantitatively monitoring therapeutic and diagnostic transgene expression induced by ex vivo and in vivo gene targeting in organs, tissues and cells |
| 09/26/2007 | EP1025212B1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 09/26/2007 | CN101041080A Chicken embryo elk bursa film blood vessel generating model and the analyzing method and use |
| 09/25/2007 | US7273611 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/25/2007 | US7273602 Immunotherapy for humans |
| 09/25/2007 | CA2204160C Treatment of urogenital cancer with boron neutron capture therapy |
| 09/20/2007 | WO2007106683A2 Biomimetic iron-oxide-containing lipoprotein and related materials |
| 09/20/2007 | WO2007106142A2 Process for using optical agents |
| 09/20/2007 | WO2005115135A3 Mouse model of crohn’s disease and a method to develop specific therapeutics |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218010 Contrast Agents for Magnetic Resonance Imaging |
| 09/20/2007 | US20070218009 Lanthanide rich nanoparticles, and their investigative uses in mri and related technologies |
| 09/20/2007 | US20070218008 Methods of screening agents, conjugates or conjugate moieties for the ability to enter the CNS by crossing the blood brain barrier in order to treat or diagnose conditions within the CNS; methods entail providing a cell expressing SVCT2 transporter, transporter being situated in plasma membrane of cell |
| 09/20/2007 | US20070218007 Ophthalmic visualization compositions and methods of using same |
| 09/20/2007 | US20070218006 Method for Monitoring Early Treatment Response |
| 09/20/2007 | US20070218005 Nuclei density and nuclei area methods for determining the effects of a botulinum toxin on muscles |
| 09/20/2007 | US20070218004 Method of Identifying Therapeutic Compounds Which Can Be Used for the Treatment and/or Prevention of Infections and Diseases Caused by Human Herpesviruses |
| 09/20/2007 | US20070218002 Method for Detecting Alzheimer's Disease and other Forms of Dementia, and Measuring Their Progression |
| 09/20/2007 | US20070218001 Biotherapeutics, Diagnostics and Research Reagents |
| 09/20/2007 | US20070218000 component of outer membrane preparations of Neisseria meningitidis capable of inducing bactericidal activity; formulations with the ability to increase the protective spectrum of existing vaccines and hence expanding it against different pathogens |
| 09/20/2007 | US20070217999 Excretable Reporter Systems |
| 09/20/2007 | US20070217996 Activatable Particles, Preparations and Uses |
| 09/20/2007 | CA2680333A1 Use of gelsolin to treat multiple sclerosis and to diagnose neurologic diseases |
| 09/20/2007 | CA2645678A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 09/20/2007 | CA2645666A1 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 09/20/2007 | CA2631226A1 Method to assess surfactant adsorption on skin |
| 09/20/2007 | CA2616147A1 Process for using optical agents |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1833513A1 Use of cyanine dyes for the diagnosis of proliferative diseases |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | EP1263803B1 Embolic compositions |
| 09/19/2007 | CN100337690C Evaluation of efficacy of medicine for moist wart |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271146 Methods for treatment of Helicobacter pylori-associated disorders |
| 09/18/2007 | US7270962 Screening for agonist or antagonist to axon outgrowth inhibitors for use in prevention and designing treatments for brain, stroke and spinal injured individuals |
| 09/18/2007 | US7270799 compounds such as 2-methyl-2(3-fluoropropyl)-malonic Acid that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, i.e., cells undergoing cell death, apoptotic cells or activated platelets |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2216919C Nanospheres comprising a biocompatible polysaccharide |
| 09/18/2007 | CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 09/13/2007 | WO2007103706A2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 09/13/2007 | WO2007103474A2 Drug adherence monitoring system |
| 09/13/2007 | WO2007102933A2 Composition for ultrasound therapy and pharmaceutical liquid composition containing the same |
| 09/13/2007 | WO2006094076A3 System and methods for preferentially enhancing activation of rac gtpase in a cell or tissue |
| 09/13/2007 | US20070212743 Assays for Determining Anticoagulant Cofactor Activity |
| 09/13/2007 | US20070212686 Use Of T-Cadherin As A Target |
| 09/13/2007 | US20070212405 Dispersion for pulmonary delivery of a bioactive agent |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212305 Optical Imaging Contrast Agents For Imaging Lung Cancer |
| 09/13/2007 | US20070212304 Method to assess surfactant adsorption on skin |
| 09/13/2007 | US20070212303 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | US20070212301 Monkey Immunoglobulin Sequences |
| 09/12/2007 | EP1830879A2 Mri guided photodynamic therapy for cancer |
| 09/12/2007 | EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 09/12/2007 | EP1307238B1 Contrast medium consisting of highly regular proteins for medical diagnostics |
| 09/12/2007 | CN101035796A Method of producing a composition, composition and its use |
| 09/12/2007 | CN101035565A Compounds, kits and methods for use in medical imaging |
| 09/12/2007 | CN101032625A Constructing method of model of lacking of Langerhans cells of small rat skin |